Drug reactions. XX. Cutaneous reactions to anticonvulsants.
D000293:Adolescent; D000328:Adult; D000505:Alopecia / Q000139:chemically induced; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003873:Dermatitis, Exfoliative / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology; D004342:Drug Hypersensitivity / Q000209:etiology; D004827:Epilepsy / Q000188:drug therapy; D004890:Erythema / Q000139:chemically induced; D005013:Ethosuximide / Q000009:adverse effects; D005260:Female; D005885:Gingival Hyperplasia / Q000139:chemically induced; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D006983:Hypertrichosis / Q000139:chemically induced; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008297:Male; D010113:Oxyphenbutazone / Q000009:adverse effects; D010859:Pigmentation Disorders / Q000139:chemically induced; D012871:Skin Diseases / Q000139:chemically induced*
D000927:Anticonvulsants; D006827:Hydantoins; D002220:Carbamazepine; D005013:Ethosuximide; D010113:Oxyphenbutazone